Literature DB >> 19072857

Structural stability of hepatitis C virus envelope glycoprotein E1: effect of pH and dissociative detergents.

Feng He1, Sangeeta B Joshi, Fons Bosman, Marijke Verhaeghe, C Russell Middaugh.   

Abstract

The hepatitis C virus (HCV) envelope glycoprotein E1 has been widely employed as a potential vaccine antigen in clinical research. A truncated form (amino acids 192-326) of the E1 protein (E1y) was expressed in the yeast Hansenula polymorpha and purified from the cell lysate. E1y forms protein particles in the absence of detergent and remains monomeric when detergent concentration is high. In this work, a variety of spectroscopic and hydrodynamic techniques including circular dichroism, intrinsic and ANS fluorescence as well as static and dynamic light scattering are employed to evaluate E1y structural stability. The effect of two dissociative detergents, Empigen BB and Zwittergent 3-12 on E1y stability, is investigated and the results are summarized using the empirical phase diagram (EPD)-based approach. The EPDs reveal that when temperature is increased, E1y particles are more thermally stable than monomers at both pH 5 and 7. A more detailed biophysical characterization of the E1y particles is also performed including pH and temperature as variables. The EPD indicates that E1y particles are most stable at pH 7 and 8 under the given experimental conditions. The results from this study provide detailed information that will help guide the future development of E1-based HCV vaccines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19072857     DOI: 10.1002/jps.21657

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  The impact of glycosylation on monoclonal antibody conformation and stability.

Authors:  Kai Zheng; Christopher Bantog; Robert Bayer
Journal:  MAbs       Date:  2011-11-01       Impact factor: 5.857

Review 2.  A rational, systematic approach for the development of vaccine formulations.

Authors:  Garry L Morefield
Journal:  AAPS J       Date:  2011-02-23       Impact factor: 4.009

Review 3.  Multidimensional methods for the formulation of biopharmaceuticals and vaccines.

Authors:  Nathaniel R Maddux; Sangeeta B Joshi; David B Volkin; John P Ralston; C Russell Middaugh
Journal:  J Pharm Sci       Date:  2011-06-06       Impact factor: 3.534

4.  A novel inactivated virus system (InViS) for a fast and inexpensive assessment of viral disintegration.

Authors:  Lea A Furer; Pietro Clement; Gordon Herwig; René M Rossi; Farien Bhoelan; Mario Amacker; Toon Stegmann; Tina Buerki-Thurnherr; Peter Wick
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

5.  Role of Ring6 in the Function of the E. coli MCE Protein LetB.

Authors:  Casey Vieni; Nicolas Coudray; Georgia L Isom; Gira Bhabha; Damian C Ekiert
Journal:  J Mol Biol       Date:  2022-01-22       Impact factor: 6.151

Review 6.  Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability.

Authors:  Tanya Clapp; Paul Siebert; Dexiang Chen; LaToya Jones Braun
Journal:  J Pharm Sci       Date:  2010-08-25       Impact factor: 3.534

7.  Purification of recombinant vaccinia virus-expressed monomeric HIV-1 gp120 to apparent homogeneity.

Authors:  Wenjin Guo; Brad Cleveland; Thaddeus M Davenport; Kelly K Lee; Shiu-Lok Hu
Journal:  Protein Expr Purif       Date:  2013-05-09       Impact factor: 1.650

8.  Unique stabilizing mechanism provided by biocompatible choline-based ionic liquids for inhibiting dissociation of inactivated foot-and-mouth disease virus particles.

Authors:  Xuan Lin; Yanli Yang; Shuai Li; Yanmin Song; Guanghui Ma; Zhiguo Su; Songping Zhang
Journal:  RSC Adv       Date:  2019-05-07       Impact factor: 3.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.